POZ - African American Hub : Treatment News : Heavy Drinking Raises Heart Disease Risk in HIV-Positive Men

POZ African American / Black Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
African American Hub News
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007


emailrssprint

December 21, 2009

Heavy Drinking Raises Heart Disease Risk in HIV-Positive Men

Binge drinking and other forms of heavy alcohol consumption increase the risk of cardiovascular disease (CVD) in men living with HIV, according to a study published by Veterans Administration researchers in the online version of the Journal of Acquired Immune Deficiency Syndromes.

Whereas moderate alcohol consumptions is believed to be associated with a reduced risk of CVD, alcohol abuse has been linked to higher rates of CVD among HIV-negative people. In people living with HIV, alcohol abuse and dependence has been linked to poor treatment adherence, chronic liver disease and HIV disease progression. Whether it is also associated with an increased risk of CVD has not been fully explored.

Matthew Freiberg, MD, of the University of Pittsburgh, and his colleagues analyzed data involving 4,742 veterans—about half of whom were HIV positive—reporting at least some alcohol use, either currently or in the past. CVD data were also available for each of the study participants.

The researchers categorized participants’ alcohol consumption using three groups: infrequent and moderate (consuming 14 or fewer drinks a week), hazardous drinking (consuming more than 14 drinks a week or binge drinking, defined as having six or more drinks on one occasion at least once a month), or alcohol abuse or dependence (a more loosely defined categorization based on a number of criteria).

Both heavy drinking and CVD were common in the cohort study. Hazardous drinking was documented in 33.2 percent of the HIV-positive men and 30.9 percent of the HIV-negative men. Alcohol abuse and dependence was found in 20.9 and 26.2 percent, respectively. CVD was confirmed in 14.6 percent and 19.8 percent, respectively.

Among the HIV-positive men, hazardous drinking raised the risk of CVD by 43 percent, and alcohol abuse and dependence raised the risk by about 55 percent, compared with infrequent or moderate drinking.

Looking only at the HIV-positive veterans and after controlling the data to exclude common traditional causes of CVD—such as age, cholesterol levels, high blood pressure and cigarette smoking—hazardous drinking was associated with a 74 percent increase in the risk of congestive heart failure (CHF), whereas alcohol abuse and dependence was associated with a 67 percent increase in the risk of coronary heart disease (CHD) and a 99 percent increased risk of CHF. Past drinkers—those who hadn’t used alcohol in the preceding 12 months—faced a 78 percent increased risk of a stroke.

Interestingly, when the researchers looked at the HIV-negative veterans and controlled for traditional risk factors, there was no statistically significant association between alcohol consumption and CVD risk. This lack of association, the authors write, “suggest[s] that the effect of alcohol may be more pronounced among those infected with HIV.”

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

Tim Horn, AIDSmeds.com, New York, NY, 2009-12-24 10:07:04
Well, the HIV-positive veterans had significantly LOWER prevalence of several cardiovascular risk factors including high cholesterol levels (the primary culprit behind ARV therapy's association with increased cardiovascular disease) compared with the HIV-negative veterans. Too early for firm conclusions? Yes. But propaganda? I think not.

Mark M, NYC, 2009-12-23 18:32:04
This another right wing garbage science study. Go back to school you idiots. We know it is the protease inhibitors. How dare you compare HIV+ veterans on meds with HIV- negative men on no meds. Shame on you for even printing this. Are you stupid or an AIDS-o-Phobe, albeit internalized. Stop this the garbage propaganda!

comments 1 - 2 (of 2 total)    


[Go to top]

Featured Video
Do you believe we can end AIDS? To find out how you can help, click here.
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS


    charliehunter
    San Francisco
    California


    Reginaldb06
    los angeles
    California


    vinamarino94
    new york city
    New York


    RayOctober
    Atlanta
    Georgia
Click here to join POZ Personals!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.